S1PR2 and breast cancer: Additionally, the S1P4 antagonist, CYM50367 or siRNA knockdown of S1P4 promoted nuclear localisation of S1P2, indicating that S1P2 and S1P4 are closely linked functionally to prevent accumulation of S1P2 in the nucleus, and to thereby promote breast cancer cell growth [18].